IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 319 filers reported holding IMMUNOMEDICS INC in Q2 2020. The put-call ratio across all filers is 0.35 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $2,849,000 | +80.8% | 33,500 | -24.7% | 0.29% | +32.4% |
| Q2 2020 | $1,576,000 | +105.2% | 44,465 | -21.9% | 0.22% | +94.6% |
| Q1 2020 | $768,000 | -45.1% | 56,965 | -13.9% | 0.11% | -33.1% |
| Q4 2019 | $1,400,000 | +45.1% | 66,182 | -9.0% | 0.17% | +26.7% |
| Q3 2019 | $965,000 | +0.1% | 72,747 | +4.6% | 0.13% | -6.4% |
| Q2 2019 | $964,000 | -27.8% | 69,517 | 0.0% | 0.14% | -36.9% |
| Q1 2019 | $1,335,000 | +34.6% | 69,517 | 0.0% | 0.22% | +16.2% |
| Q4 2018 | $992,000 | – | 69,517 | – | 0.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Avoro Capital Advisors LLC | 10,488,076 | $92,610,000 | 11.69% |
| First Light Asset Management, LLC | 2,048,643 | $18,090,000 | 6.07% |
| Foresite Capital Management III, LLC | 1,940,850 | $17,138,000 | 5.60% |
| DAFNA Capital Management LLC | 637,700 | $5,631,000 | 4.02% |
| ACUTA CAPITAL PARTNERS, LLC | 1,600,000 | $14,128,000 | 3.95% |
| Opaleye Management Inc. | 900,000 | $7,947,000 | 3.32% |
| Ghost Tree Capital, LLC | 1,200,000 | $10,596,000 | 2.20% |
| Iguana Healthcare Management, LLC | 325,000 | $2,870,000 | 1.62% |
| Healthcare Value Capital, LLC | 100,000 | $883,000 | 1.59% |
| Palo Alto Investors LP | 3,010,466 | $26,582,000 | 1.24% |